Upcoming Dividend • Mar 19
Upcoming dividend of ₺8.14 per share Eligible shareholders must have bought the stock before 26 March 2026. Payment date: 30 March 2026. Payout ratio is a comfortable 41% and this is well supported by cash flows. Trailing yield: 4.7%. Within top quartile of Turkish dividend payers (2.8%). Higher than average of industry peers (3.1%). Announcement • Mar 02
Anadolu Hayat Emeklilik Anonim Sirketi, Annual General Meeting, Mar 24, 2026 Anadolu Hayat Emeklilik Anonim Sirketi, Annual General Meeting, Mar 24, 2026. Location: oditoryum binasi is kuleleri 34330 levent-besiktas, istanbul Turkey Declared Dividend • Mar 02
Dividend increased to ₺8.14 Dividend of ₺8.14 is 40% higher than last year. Ex-date: 26th March 2026 Payment date: 30th March 2026 Dividend yield will be 7.3%, which is higher than the industry average of 3.4%. Sustainability & Growth Dividend is well covered by both earnings (41% earnings payout ratio) and cash flows (27% cash payout ratio). The dividend has increased by an average of 48% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 63% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Announcement • Feb 28
Anadolu Hayat Emeklilik Anonim Sirketi announces Annual dividend, payable on March 30, 2026 Anadolu Hayat Emeklilik Anonim Sirketi announced Annual dividend of TRY 8.1395 per share payable on March 30, 2026, ex-date on March 26, 2026 and record date on March 27, 2026. Reported Earnings • Feb 01
Full year 2025 earnings released: EPS: ₺13.94 (vs ₺10.01 in FY 2024) Full year 2025 results: EPS: ₺13.94 (up from ₺10.01 in FY 2024). Revenue: ₺37.8b (up 62% from FY 2024). Net income: ₺5.99b (up 39% from FY 2024). Profit margin: 16% (down from 18% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 87% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Oct 27
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 99x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (over 99x increase in shares outstanding). Minor Risk Dividend is not well covered by cash flows (dividend per share is over 21x cash flows per share). Reported Earnings • Oct 26
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: ₺9.79b (up 68% from 3Q 2024). Net income: ₺1.55b (up 100% from 3Q 2024). Profit margin: 16% (up from 13% in 3Q 2024). The increase in margin was driven by higher revenue. Reported Earnings • Aug 06
Second quarter 2025 earnings released: EPS: ₺3.30 (vs ₺2.84 in 2Q 2024) Second quarter 2025 results: EPS: ₺3.30 (up from ₺2.84 in 2Q 2024). Revenue: ₺9.23b (up 74% from 2Q 2024). Net income: ₺1.42b (up 16% from 2Q 2024). Profit margin: 15% (down from 23% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has increased by 84% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Aug 06
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 99x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (over 99x increase in shares outstanding). Minor Risk Dividend is not well covered by cash flows (dividend per share is over 24x cash flows per share). Price Target Changed • Jul 21
Price target decreased by 7.3% to ₺150 Down from ₺162, the current price target is an average from 3 analysts. New target price is 80% above last closing price of ₺83.45. Stock is down 37% over the past year. The company posted earnings per share of ₺10.01 last year. Announcement • Apr 25
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q1, 2025 Results on Apr 25, 2025 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q1, 2025 results on Apr 25, 2025 Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₺90.70, the stock trades at a trailing P/E ratio of 9.1x. Average forward P/E is 10x in the Insurance industry in Turkey. Total returns to shareholders of 632% over the past three years. Upcoming Dividend • Mar 19
Upcoming dividend of ₺5.81 per share Eligible shareholders must have bought the stock before 26 March 2025. Payment date: 28 March 2025. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of Turkish dividend payers (2.6%). Lower than average of industry peers (3.0%). Declared Dividend • Mar 02
Dividend of ₺5.81 announced Shareholders will receive a dividend of ₺5.81. Ex-date: 26th March 2025 Payment date: 28th March 2025 Dividend yield will be 5.8%, which is higher than the industry average of 3.4%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has increased by an average of 35% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 64% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Feb 07
Full year 2024 earnings released: EPS: ₺10.01 (vs ₺6.64 in FY 2023) Full year 2024 results: EPS: ₺10.01 (up from ₺6.64 in FY 2023). Revenue: ₺23.3b (up 43% from FY 2023). Net income: ₺4.31b (up 51% from FY 2023). Profit margin: 19% (up from 18% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has increased by 88% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 06
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q4, 2024 Results on Feb 06, 2025 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q4, 2024 results on Feb 06, 2025 Reported Earnings • Oct 28
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: ₺5.86b (up 57% from 3Q 2023). Net income: ₺776.7m (up 9.2% from 3Q 2023). Profit margin: 13% (down from 19% in 3Q 2023). The decrease in margin was driven by higher expenses. Announcement • Oct 24
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q3, 2024 Results on Oct 25, 2024 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q3, 2024 results on Oct 25, 2024 New Risk • Aug 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 10.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10.0% average weekly change). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Jul 31
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: ₺5.28b (down 6.8% from 2Q 2023). Net income: ₺1.22b (up 36% from 2Q 2023). Profit margin: 23% (up from 16% in 2Q 2023). The increase in margin was driven by lower expenses. Valuation Update With 7 Day Price Move • Jul 30
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₺106, the stock trades at a trailing P/E ratio of 13.2x. Average forward P/E is 12x in the Insurance industry in Turkey. Total returns to shareholders of 1,241% over the past three years. Announcement • Jul 26
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q2, 2024 Results on Jul 29, 2024 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q2, 2024 results on Jul 29, 2024 Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₺131, the stock trades at a trailing P/E ratio of 16.3x. Average forward P/E is 10x in the Insurance industry in Turkey. Total returns to shareholders of 1,678% over the past three years. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to ₺117, the stock trades at a trailing P/E ratio of 14.5x. Average forward P/E is 11x in the Insurance industry in Turkey. Total returns to shareholders of 1,393% over the past three years. Valuation Update With 7 Day Price Move • May 22
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₺81.00, the stock trades at a trailing P/E ratio of 10.1x. Average forward P/E is 12x in the Insurance industry in Turkey. Total returns to shareholders of 936% over the past three years. Price Target Changed • May 10
Price target increased by 21% to ₺82.83 Up from ₺68.70, the current price target is an average from 3 analysts. New target price is 19% above last closing price of ₺69.35. Stock is up 313% over the past year. The company posted earnings per share of ₺6.64 last year. Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₺65.45, the stock trades at a trailing P/E ratio of 8.1x. Average forward P/E is 11x in the Insurance industry in Turkey. Total returns to shareholders of 793% over the past three years. Reported Earnings • May 02
First quarter 2024 earnings released: EPS: ₺2.33 (vs ₺0.92 in 1Q 2023) First quarter 2024 results: EPS: ₺2.33 (up from ₺0.92 in 1Q 2023). Revenue: ₺5.63b (up 150% from 1Q 2023). Net income: ₺999.8m (up 152% from 1Q 2023). Profit margin: 18% (in line with 1Q 2023). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has increased by 89% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₺41.90, the stock trades at a trailing P/E ratio of 6.3x. Average forward P/E is 10x in the Insurance industry in Turkey. Total returns to shareholders of 437% over the past three years. Announcement • Mar 24
Anadolu Hayat Emeklilik Anonim Sirketi, Annual General Meeting, Mar 22, 2024 Anadolu Hayat Emeklilik Anonim Sirketi, Annual General Meeting, Mar 22, 2024, at 07:00 Coordinated Universal Time. Location: Oditoryum Binasi Is Kuleleri 34330 Levent, Istanbul Turkey Agenda: To consider Opening, determining the Meeting Presidency, and authorizing the signing of the Ordinary General Assembly meeting minutes by the Meeting Presidency; to consider Reading and negotiating the Activity Report of the Board of Directors for 2023 and reading the Report of the Independent Audit Institution; to consider Reading, negotiating, and approving the financial statements for 2023; to consider Release of the Members of the Board of Directors; and to consider other matters. Upcoming Dividend • Mar 19
Upcoming dividend of ₺2.33 per share Eligible shareholders must have bought the stock before 26 March 2024. Payment date: 28 March 2024. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 2.4%. Within top quartile of Turkish dividend payers (1.9%). Lower than average of industry peers (3.5%). Reported Earnings • Feb 08
Full year 2023 earnings released Full year 2023 results: Revenue: ₺16.5b (up 112% from FY 2022). Net income: ₺2.85b (up 111% from FY 2022). Profit margin: 17% (in line with FY 2022). New Risk • Feb 08
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 99x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (over 99x increase in shares outstanding). Minor Risk Dividend is not well covered by cash flows (dividend per share is over 13x cash flows per share). Announcement • Feb 06
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q4, 2023 Results on Feb 06, 2024 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q4, 2023 results on Feb 06, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: ₺1.71 (vs ₺0.96 in 3Q 2022) Third quarter 2023 results: EPS: ₺1.71 (up from ₺0.96 in 3Q 2022). Revenue: ₺3.85b (up 86% from 3Q 2022). Net income: ₺735.2m (up 79% from 3Q 2022). Profit margin: 19% (in line with 3Q 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 27
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q3, 2023 Results on Oct 30, 2023 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q3, 2023 results on Oct 30, 2023 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₺51.70, the stock trades at a trailing P/E ratio of 9.6x. Average forward P/E is 9x in the Insurance industry in Turkey. Total returns to shareholders of 732% over the past three years. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₺37.38, the stock trades at a trailing P/E ratio of 6.9x. Average forward P/E is 9x in the Insurance industry in Turkey. Total returns to shareholders of 532% over the past three years. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₺22.82, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 9x in the Insurance industry in Turkey. Total returns to shareholders of 213% over the past three years. Reported Earnings • May 01
First quarter 2023 earnings released: EPS: ₺0.92 (vs ₺0.44 in 1Q 2022) First quarter 2023 results: EPS: ₺0.92 (up from ₺0.44 in 1Q 2022). Revenue: ₺2.26b (up 47% from 1Q 2022). Net income: ₺393.5m (up 107% from 1Q 2022). Profit margin: 17% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₺15.57, the stock trades at a trailing P/E ratio of 4.8x. Average forward P/E is 9x in the Insurance industry in Turkey. Total returns to shareholders of 254% over the past three years. Upcoming Dividend • Mar 21
Upcoming dividend of ₺1.16 per share at 5.8% yield Eligible shareholders must have bought the stock before 28 March 2023. Payment date: 30 March 2023. Payout ratio is a comfortable 42% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of Turkish dividend payers (2.7%). Higher than average of industry peers (4.1%). Reported Earnings • Feb 05
Full year 2022 earnings released: EPS: ₺3.24 (vs ₺1.63 in FY 2021) Full year 2022 results: EPS: ₺3.24 (up from ₺1.63 in FY 2021). Revenue: ₺7.86b (up 60% from FY 2021). Net income: ₺1.39b (up 99% from FY 2021). Profit margin: 18% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 34% per year. Valuation Update With 7 Day Price Move • Feb 03
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₺17.18, the stock trades at a trailing P/E ratio of 7x. Average forward P/E is 10x in the Insurance industry in Turkey. Total returns to shareholders of 183% over the past three years. Announcement • Feb 02
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q4, 2022 Results on Feb 02, 2023 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q4, 2022 results on Feb 02, 2023 Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Murat Bolat was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Third quarter 2022 earnings released: EPS: ₺0.96 (vs ₺0.40 in 3Q 2021) Third quarter 2022 results: EPS: ₺0.96 (up from ₺0.40 in 3Q 2021). Revenue: ₺2.08b (up 146% from 3Q 2021). Net income: ₺411.8m (up 138% from 3Q 2021). Profit margin: 20% (in line with 3Q 2021). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 27
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q3, 2022 Results on Oct 27, 2022 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q3, 2022 results on Oct 27, 2022 Reported Earnings • Aug 01
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: ₺1.91b (up 143% from 2Q 2021). Net income: ₺182.9m (up 49% from 2Q 2021). Profit margin: 9.6% (down from 16% in 2Q 2021). The decrease in margin was driven by higher expenses. Announcement • Jul 28
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q2, 2022 Results on Jul 28, 2022 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q2, 2022 results on Jul 28, 2022 Reported Earnings • May 01
First quarter 2022 earnings released: EPS: ₺0.44 (vs ₺0.31 in 1Q 2021) First quarter 2022 results: EPS: ₺0.44 (up from ₺0.31 in 1Q 2021). Revenue: ₺1.55b (up 75% from 1Q 2021). Net income: ₺189.7m (up 44% from 1Q 2021). Profit margin: 12% (down from 15% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 33% per year and the company’s share price has also increased by 33% per year. Price Target Changed • Apr 27
Price target increased to ₺16.45 Up from ₺13.00, the current price target is provided by 1 analyst. New target price is 29% above last closing price of ₺12.80. Stock is up 43% over the past year. The company posted earnings per share of ₺1.63 last year. Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Murat Bolat was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₺13.08, the stock trades at a trailing P/E ratio of 8x. Average forward P/E is 9x in the Insurance industry in Turkey. Total returns to shareholders of 211% over the past three years. Upcoming Dividend • Mar 18
Upcoming dividend of ₺1.02 per share Eligible shareholders must have bought the stock before 25 March 2022. Payment date: 29 March 2022. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 5.2%. Within top quartile of Turkish dividend payers (3.7%). Higher than average of industry peers (4.1%). Reported Earnings • Jan 30
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: ₺1.63 (up from ₺1.23 in FY 2020). Revenue: ₺4.91b (up 70% from FY 2020). Net income: ₺700.0m (up 33% from FY 2020). Profit margin: 14% (down from 18% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Executive Departure • Sep 08
Deputy CEO & Member of Executive Board Mustafa Aytekin has left the company During their tenure, earnings grew by 29% annually compared to the industry average, which went down by 1.4%. We don't have any record of a personal shareholding under Mustafa's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.67 years, which is considered inexperienced in the Simply Wall St Risk Model. Reported Earnings • Aug 11
Second quarter 2021 earnings released: EPS ₺0.28 (vs ₺0.30 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: ₺786.6m (up 21% from 2Q 2020). Net income: ₺122.7m (down 5.3% from 2Q 2020). Profit margin: 16% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 29
First quarter 2021 earnings released: EPS ₺0.31 (vs ₺0.29 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: ₺882.8m (up 9.7% from 1Q 2020). Net income: ₺131.7m (up 5.3% from 1Q 2020). Profit margin: 15% (in line with 1Q 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₺9.37, the stock trades at a trailing P/E ratio of 7.6x. Average forward P/E is 10x in the Insurance industry in Turkey. Total returns to shareholders of 58% over the past three years. Upcoming Dividend • Mar 22
Upcoming Dividend of ₺0.84 Per Share Will be paid on the 31st of March to those who are registered shareholders by the 29th of March. The trailing yield of 5.5% is in the top quartile of Turkish dividend payers (2.5%), and it is higher than industry peers (3.2%). Reported Earnings • Jan 30
Full year 2020 earnings released: EPS ₺1.23 (vs ₺0.84 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: ₺2.90b (up 40% from FY 2019). Net income: ₺526.9m (up 46% from FY 2019). Profit margin: 18% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Announcement • Jan 28
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q4, 2020 Results on Jan 28, 2021 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q4, 2020 results on Jan 28, 2021 Is New 90 Day High Low • Jan 04
New 90-day high: ₺8.92 The company is up 14% from its price of ₺7.83 on 06 October 2020. The Turkish market is up 22% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Insurance industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₺4.14 per share. Reported Earnings • Oct 29
Third quarter earnings released Over the last 12 months the company has reported total profits of ₺513.8m, up 74% from the prior year. Total revenue was ₺3.15b over the last 12 months, up 110% from the prior year. Is New 90 Day High Low • Oct 22
New 90-day high: ₺8.74 The company is up 1.0% from its price of ₺8.62 on 24 July 2020. The Turkish market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₺3.41 per share. Announcement • Jul 26
Anadolu Hayat Emeklilik Anonim Sirketi to Report Q2, 2020 Results on Jul 28, 2020 Anadolu Hayat Emeklilik Anonim Sirketi announced that they will report Q2, 2020 results on Jul 28, 2020 
